Treatment of post-myocardial infarction depressive disorder: A randomized, placebo-controlled trial with mirtazapine

Psychosomatic Medicine

Volumn 69, Issue 7, 2007, Pages 606-613

  Honig, Adriaan ^e   Kuyper, Astrid M G ^a   Schene, Aart H ^a   Van Melle, Joost P ^b   De Jonge, Peter ^b   Tulner, Dorien M ^c   Schins, Annique ^d   Crijns, Harry J G M ^d   Kuijpers, Petra M J C ^d   Vossen, Helen ^d   Lousberg, Richel ^d   Ormel, Johan ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MEDICAL CENTER LEEUWARDEN   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Antidepressive treatment; Depressive disorder; Mirtazapine; Post myocardial infarction

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MIRTAZAPINE; NITRATE; PLACEBO;

ADULT; ANGINA PECTORIS; APPETITE; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DYSPNEA; FATIGUE; FEMALE; HAMILTON SCALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART PALPITATION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PR INTERVAL; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYMPTOM CHECKLIST 90;

EID: 34648829804     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31814b260d     Document Type: Article

References (24)

1. Strik JMH, Lousberg R, Cherieux EC, Honig A. One year cumulative incidence of depression after myocardial infarction and impact on cardiac outcome. J Psychosom Res 2004;56:59-66.
2. Melle JP van, Jonge P de, Spijkerman TA, Tijssen JGP, Ormel J, Veldhuisen D van, Brink RHS van den, Berg MP van den. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004;66:814-22.
3. Rapaport MH, Judd LL, Shettler PJ, Yonkers KA, Thase, ME, Kupfer DJ, Frank E, Plewes, JM, Tollefson GD, Rush AJ. A descriptive analysis of minor depression. Am J Psychiatry 2002;159:637-43.
4. Penninx BWJH, Beekman ATF, Honig A, Deeg DJH, Schoevers RA, Eijk van JTM, Tilburg van W. Depression and cardiac mortality. Arch Gen Psychiatry 2001;58:221-7.
5. McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR, Blackburn H, Luepker RV. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med 1996;334:884-90.
6. Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction: a prospective, population - based study of the elderly. Ann Intern Med 1992;117:1003-9.
7. Case RB, Moss AJ, Case N, McDermott M, Eberly S. Living alone after myocardial infarction. JAMA 1992;267:515-9.
8. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993;270:1819-25.
9. de Jonge P, Spijkerman TA, van den Brink RHS, Ormel J. Depression following myocardial infarction is a risk factor for declined health-related quality of life and increased disability and cardiac complaints at 12 months. Heart 2006;92:32-9.
10. Carney RM, Blumenthal JA, Freedland KE, Youngblood MMA, Veith RC, Burg MM, Cornell C, Saab PG, Kaufmann PG, Czajkowski SM, Jaffe AS, for the ENRICHD Investigators. Depression and late mortality after myocardial infarction in the enhancing recovery in coronary heart disease (ENRICHD) study. Psychosom Med 2004;66:466-74.
11. Writing Committee for the ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction. JAMA 2003;289:3106-16.
12. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, Krishnan KRR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM, for the Sertraline Antidepressant Heart Attack Randomized Trial Group. Sertraline treatment of major depression in patients with acute mi or unstable angina. JAMA 2002;288:701-9.
13. Strik JM, Honig A, Lousberg R, Lousberg AHP, Cheriex EC, Tuynman-Qua HG, Kuijpers PMJC, Wellens HJJ, Van Praag HM. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 2000;62:783-9.
14. Lespérance F, Frasure-Smith N, Koszycki D, Laliberté MA, van Zyl LT, Baker B, Swenson JR, Ghatave K, Abramson BL, Dorian P, Guertin MC, for the CREATE investigators. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary disease. JAMA 2007;297:367-79.
15. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287-91.
16. Smulevich AB, Drobijev M Y, Ilina NA. Mirtazapine in treatment of depression in patients with ischaemic heart disease. Eur Neuropsychopharmacol 2001; 11(Suppl 3):S205-6.
17. Brink RHS van den, Melle JP van, Honig A, Schene AH, Crijns HJGM, Lambert FPG, Ormel J, for the MIND-IT Investigators. Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the myocardial infarction and depression-intervention trial (MIND-IT). Am Heart J 2002;144:219-25.
18. Strik JJMH, Honig A, Lousberg R, Denollet J. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 2001;42:423-8.
19. World Health Organization. CIDI-Core. Composite international diagnostic interview, core version. Geneva: Division of Mental Health, WHO; 1990.
20. Hamilton M. The Hamilton rating scale for depression. In: Sartorius N, Ban TA, editors. Assessment of depression. New York: Springer; 1986.
21. Arrindell WA, Ettema JHM. SCL-90. Handleiding bij een multidimensioneel psychopathologie-indicator. Lisse: Swers & Zeitinger; 1975.
22. Knapp RG, Miller MC. Clinical epidemiology and biostatistics. Baltimore: Williams & Wilkins; 1992.
23. Hair JF, Anderson RE, Tatham RL, Black WC. Multivariate data analysis. New Jersey: Prentice Hall; 1998.
24. Judd LL, Rapaport MH, Yonkers KA, Rush AJ, Frank E, Thase ME, Kupfer DJ, Plewes JM, Schettler PJ, Tollefson G. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive Disorder. Am J Psychiatry 2004;161:1864-71.